Leucine Rich Bio Partners with Precision Diagnosticos to Expand Microbiome Testing in Brazil

The collaboration aims to improve accessibility to advanced microbiome diagnostics and personalized health solutions in both regions.

Bengaluru-based Leucine Rich Bio has announced a strategic partnership with Brazil’s Precision Diagnosticos to introduce its microbiome testing technology,

BugSpeaks, to the Brazilian market.

The collaboration aims to improve accessibility to advanced microbiome diagnostics and personalized health solutions in both regions.

Leucine Rich Bio, South Asia’s first microbiome-focused company, has partnered with Precision Diagnosticos, a well-established diagnostics firm in Brazil, to bring its flagship microbiome testing tool, BugSpeaks, to a broader audience.

BugSpeaks is a gut microbiome analysis tool that identifies microbial imbalances linked to health conditions such as obesity, diabetes, and digestive disorders. The partnership will leverage Precision Diagnosticos’ expertise and distribution network to ensure greater availability of microbiome testing in Brazil.

Beyond expanding diagnostic access, the partnership also focuses on education and awareness regarding gut health.

As part of the collaboration, healthcare professionals in Brazil will receive training and resources to integrate microbiome testing into routine clinical practice.

Additionally, targeted awareness campaigns will be launched to educate the public and medical community on the role of microbiome health in overall well-being.